Authors:
Vansteenkiste, J
Gatzemeier, U
Manegold, C
Hanauske, A
Weynants, P
Bosquee, L
Blatter, J
Mansouri, K
von Pawel, J
Citation: J. Vansteenkiste et al., Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study, ANN ONCOL, 12(6), 2001, pp. 835-840
Authors:
von Pawel, J
Gatzemeier, U
Pujol, JL
Moreau, L
Bildat, S
Ranson, M
Richardson, G
Steppert, C
Riviere, A
Camlett, I
Lane, S
Ross, G
Citation: J. Von Pawel et al., Phase II comparator study of oral versus intravenous topotecan in patientswith chemosensitive small-cell lung cancer, J CL ONCOL, 19(6), 2001, pp. 1743-1749
Authors:
Schuler, M
Herrmann, R
De Greve, JLP
Stewart, AK
Gatzemeier, U
Stewart, DJ
Laufman, L
Gralla, R
Kuball, J
Buhl, R
Heussel, CP
Kommoss, F
Perruchoud, AP
Shepherd, FA
Fritz, MA
Horowitz, JA
Huber, C
Rochlitz, C
Citation: M. Schuler et al., Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study, J CL ONCOL, 19(6), 2001, pp. 1750-1758
Authors:
Mattson, K
Vansteenkiste, J
Stupp, R
Bargetzi, M
Saarinen, A
Jekunen, A
Fillet, G
Teixeira, M
Gatzemeier, U
Olivares, R
Soussan-Lazard, K
Berille, J
Citation: K. Mattson et al., Phase II study of docetaxel alternating with cisplatin in chemotherapy-naive patients with advanced non-small cell lung cancer, ANTI-CANC D, 11(1), 2000, pp. 7-13
Authors:
Manegold, C
Gatzemeier, U
von Pawel, J
Pirker, R
Malayeri, R
Blatter, J
Krejcy, K
Citation: C. Manegold et al., Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA (TM)) and cisplatin: A multicenter phase II trial, ANN ONCOL, 11(4), 2000, pp. 435-440
Authors:
von Pawel, J
von Roemeling, R
Gatzemeier, U
Boyer, M
Elisson, LO
Clark, P
Talbot, D
Rey, A
Butler, TW
Hirsh, V
Olver, I
Bergman, B
Ayoub, J
Richrdson, G
Dunlop, D
Arcenas, A
Vescio, R
Viallet, J
Treat, J
Citation: J. Von Pawel et al., Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group, J CL ONCOL, 18(6), 2000, pp. 1351-1359
Authors:
Gatzemeier, U
von Pawel, J
Gottfried, M
ten Velde, GPM
Mattson, K
DeMarinis, F
Harper, P
Salvati, F
Robinet, G
Lucenti, A
Bogaerts, J
Gallant, G
Citation: U. Gatzemeier et al., Phase III comparative study of high-dose cisplatin versus a combination ofpaclitaxel and cisplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 18(19), 2000, pp. 3390-3399
Authors:
Sandler, AB
Nemunaitis, J
Denham, C
von Pawel, J
Cormier, Y
Gatzemeier, U
Mattson, K
Manegold, C
Palmer, MC
Gregor, A
Nguyen, B
Niyikiza, C
Einhorn, LH
Citation: Ab. Sandler et al., Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 18(1), 2000, pp. 122-130
Authors:
Gatzemeier, U
Kleisbauer, JP
Drings, P
Kaukel, E
Samaras, N
Melo, MJ
Cardenal, F
Robinet, G
Snijder, RJ
von Pawel, J
Palisses, R
Citation: U. Gatzemeier et al., Lenograstim as support for ACE chemotherapy of small-cell lung cancer - A phase III, multicenter, randomized study, AM J CL ONC, 23(4), 2000, pp. 393-400